My bookmarksSign up free
Source

Commission Decision of 14 December 2009 on financial aid from the Union for the year 2010 for certain Community reference laboratories in the field of animal health and live animals (notified under document C(2009) 9965)

Commission Decision of 14 December 2009 on financial aid from the Union for the year 2010 for certain Community reference laboratories in the field of animal health and live animals (notified under document C(2009) 9965)

Decision · 18 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

For African horse sickness, the Union grants financial assistance to the Laboratorio Central de Sanidad Animal de Algete, Algete (Madrid), Spain, to carry out the functions and duties set out in Annex III to Directive 92/35/EEC. The Union’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 150 000 for the period from 1 January to 31 December 2010, of which a maximum of EUR 50 000 shall be dedicated to the organisation of a technical workshop on African horse sickness. As mentioned in Article 13(3) of Regulation (EC) No 1754/2006, the laboratory referred to in the first paragraph shall be entitled to claim financial assistance for attendance by a maximum of 50 participants at its workshop referred to in the second paragraph of this Article as it will organise a joint workshop.

Article 2

Open ↗

For Newcastle disease, the Union grants financial assistance to the Veterinary Laboratories Agency (VLA), New Haw, Weybridge, United Kingdom, to carry out the functions and duties set out in Annex V to Directive 92/66/EEC. The Union’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 88 000 for the period from 1 January to 31 December 2010.

Article 3

Open ↗

For swine vesicular disease, the Union grants financial assistance to the AFRC Institute for Animal Health, Pirbright Laboratory, Pirbright, United Kingdom, to carry out the functions and duties set out in Annex III to Directive 92/119/EEC. The Union’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 120 000 for the period from 1 January to 31 December 2010.

Article 4

Open ↗

For fish diseases, the Union grants financial assistance to the Technical University of Denmark, National Veterinary Institute, Department of Poultry, Fish and Fur Animals, Århus, Denmark, to carry out the functions and duties set out in Annex VI to Directive 2006/88/EC. The Union’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 255 000 for the period from 1 January to 31 December 2010.

Article 5

Open ↗

For diseases of bivalve molluscs, the Union grants financial assistance to the Ifremer, La Tremblade, France, to carry out the functions and duties set out in Annex VI to Directive 2006/88/EC. The Union’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that institute for the work programme and shall amount to a maximum of EUR 105 000 for the period from 1 January to 31 December 2010.

Article 6

Open ↗

For rabies serology, the Union grants financial assistance to the AFSSA, Laboratoire d’études sur la rage et la pathologie des animaux sauvages, Nancy, France, to carry out the functions and duties set out in Annex II to Decision 2000/258/EC. The Union’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 140 000 for the period from 1 January to 31 December 2010.

Article 7

Open ↗

For bluetongue, the Union grants financial assistance to the AFRC Institute for Animal Health, Pirbright Laboratory, Pirbright, United Kingdom, to carry out the functions and duties set out in Annex II(B) to Directive 2000/75/EC. The Union’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 280 000 for the period from 1 January to 31 December 2010.

Article 8

Open ↗

For classical swine fever, the Union grants financial assistance to the Institut für Virologie der Tierärztlichen Hochschule Hannover, Hannover, Germany, to carry out the functions and duties set out in Annex IV to Directive 2001/89/EC. The Union’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that institute for the work programme and shall amount to a maximum of EUR 385 000 for the period from 1 January to 31 December 2010 of which a maximum of EUR 25 000 shall be dedicated to the organisation of a technical workshop on classical swine fever.

Article 9

Open ↗

For African swine fever, the Union grants financial assistance to the Centro de Investigación en Sanidad Animal, Valdeolmos, Madrid, Spain, to carry out the functions and duties set out in Annex V to Directive 2002/60/EC. The Union’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that research centre for the work programme and shall amount to a maximum of EUR 140 000 for the period from 1 January to 31 December 2010.

Article 10

Open ↗

For foot-and-mouth disease, the Union grants financial assistance to the Institute for Animal Health, Pirbright Laboratory, of the Biotechnology and Biological Sciences Research Council (BBSRC), Pirbright, United Kingdom, to carry out the functions and duties set out in Annex XVI to Directive 2003/85/EC. The Union’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 350 000 for the period from 1 January to 31 December 2010.

Article 11

Open ↗

For collaborating in rendering uniform the testing methods and the assessment of the results for pure-bred breeding animals of the bovine species, the Union grants financial assistance to the Interbull Centre, Department of Animal Breeding and Genetics, Swedish University of Agricultural Sciences, Uppsala, Sweden, to carry out the functions and duties set out in Annex II to Decision 96/463/EC. The Union’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that centre for the work programme and shall amount to a maximum of EUR 150 000 for the period from 1 January to 31 December 2010.

Article 12

Open ↗

For brucellosis, the Union grants financial assistance to the AFSSA, Laboratoire d’études et de recherches en pathologie animale et zoonoses, Maisons-Alfort, France, to carry out the functions and duties set out in Article 32(2) of Regulation (EC) No 882/2004. The Union’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 240 000 for the period from 1 January to 31 December 2010.

Article 13

Open ↗

For avian influenza, the Union grants financial assistance to the Veterinary Laboratories Agency (VLA), New Haw, Weybridge, United Kingdom, to carry out the functions and duties set out in Annex VII to Directive 2005/94/EC. The Union’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 380 000 for the period from 1 January to 31 December 2010.

Article 14

Open ↗

For crustacean diseases, the Union grants financial assistance to the Centre for Environment, Fisheries & Aquaculture Science (Cefas), Weymouth Laboratory, United Kingdom, to carry out the functions and duties set out in Part I Annex VI to Directive 2006/88/EC. The Union’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 140 000 for the period from 1 January to 31 December 2010 of which a maximum of EUR 30 000 shall be dedicated to the organisation of a technical workshop on crustacean diseases.

Article 15

Open ↗

For equine diseases other than African Horse Sickness, the Union grants financial assistance to the AFSSA, Laboratoire d’études et de recherches en pathologie animale et zoonoses/Laboratoire d’études et de recherche en pathologie equine, France, to carry out the functions and duties set out in the Annex to Regulation (EC) No 180/2008. The Union’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 530 000 for the period from 1 January to 31 December 2010 of which a maximum of EUR 30 000 shall be dedicated to the organisation of a technical workshop on equine diseases.

Article 16

Open ↗

For rabies, the Union grants financial assistance to the AFSSA, Laboratoire d’études sur la rage et la pathologie des animaux sauvages, Nancy, France, to carry out the functions and duties set out in Annex I to Regulation (EC) No 737/2008. The Union’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 275 000 for the period from 1 January to 31 December 2010, of which a maximum of EUR 25 000 shall be dedicated to the organisation of a technical workshop on rabies.

Article 17

Open ↗

For tuberculosis, the Union grants financial assistance to the Laboratorio de Vigilancia Veterinaria (Visavet) of the Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid, Spain, to carry out the functions and duties set out in Annex II to Regulation (EC) No 737/2008. The Union’s financial assistance shall be at the rate of 100 % of the eligible costs as defined in Regulation (EC) No 1754/2006 to be incurred by that laboratory for the work programme and shall amount to a maximum of EUR 150 000 for the period from 1 January to 31 December 2010.

Article 18

Open ↗

This Decision is addressed to: — for African horse sickness: Laboratorio Central de Sanidad Animal, Ministerio de Agricultura, PESCA y Alimentación, Ctra. De Algete km. 8, Valdeolmos, 28110 Algete (Madrid), Spain, — for Newcastle Disease: Veterinary Laboratories Agency, Weybridge, New Haw, Addelstone, Surrey, KT15 3NB, United Kingdom, — for Swine vesicular disease: AFRC Institute for Animal Health, Pirbright Laboratory, Pirbright, Woking, Surrey, GU24 0NF, United Kingdom, — for fish diseases: the Technical University of Denmark, National Veterinary Institute, Department of Poultry, Fish and Fur Animals, Hangøvej 2, 8200 Århus, Denmark, — for diseases of bivalve molluscs: Ifremer, B.P. 133, 17390 La Tremblade, France, — for rabies serology: AFSSA, Laboratoire d’études sur la rage et la pathologie des animaux sauvages, site de Nancy, Domaine de Pixérécourt, B.P. 9, 54220 Malzéville, France, — for bluetongue: AFRC Institute for Animal Health, Pirbright Laboratory, Pirbright, Woking, Surrey, GU24 0NF, United Kingdom, — for classical swine fever: Institut für Virologie der Tierärztlichen Hochschule, Bischofsholer Damm 15, 30173 Hannover, Germany, — for African swine fever: Centro de Investigación en Sanidad Animal, Ctra. De Algete a El Casar, Valdeolmos, 28130 Madrid, Spain, — for foot-and-mouth disease: AFRC Institute for Animal Health, Pirbright Laboratory, Pirbright, Woking, Surrey, GU24 0NF, United Kingdom, — Interbull Centre, Department of Animal Breeding and Genetics SLU, Swedish University of Agricultural Sciences, Box 7023; SE-750 07 Uppsala, Sweden, — for brucellosis: AFSSA, Laboratoire d’études et de recherches en pathologie animale et zoonoses, 23 avenue du Général de Gaulle, 94706 Maisons-Alfort, Cedex France, — for Avian influenza: Veterinary Laboratories Agency, Weybridge, New Haw, Addelstone, Surrey, KT15 3NB, United Kingdom, — for crustacean diseases: Centre for Environment, Fisheries & Aquaculture Science (Cefas), Weymouth Laboratory, The Nothe, Barrack Road, Weymouth, Dorset, DT4 8UB, United Kingdom, — for equine diseases: AFSSA, Laboratoire d’études et de recherches en pathologie animale et zoonoses, 23 avenue du Général de Gaulle, 94706 Maisons-Alfort, Cedex France, — for rabies: AFSSA, Laboratoire d’études sur la rage et la pathologie des animaux sauvages, site de Nancy, Domaine de Pixérécourt, B.P. 9, 54220 Malzéville, France, — for tuberculosis: Visavet — Laboratorio de vigilancia veterinaria, Facultad de Veterinaria, Universidad Complutense de Madrid, Avda. Puerta de Hierro, s/n. Ciudad Universitaria, 28040 Madrid, Spain.

Other acts of the same type
2011/806/EU: Commission Implementing Decision of 30 November 2011 establishing the financial contribution by the Union to the expenditure incurred in the context of the emergency vaccination plans against bluetongue in Luxembourg in 2007 and 2008 (notified under document C(2011) 8742)2011/807/EU: Commission Implementing Decision of 30 November 2011 approving annual and multiannual programmes and the financial contribution from the Union for the eradication, control and monitoring of certain animal diseases and zoonoses presented by the Member States for 2012 and following years (notified under document C(2011) 8719)2011/809/EU: Council Decision of 30 November 2011 on the position to be taken by the European Union within the General Council of the World Trade Organization on the extension of the WTO waiver in order to implement the EU autonomous preferential trade regime for the Western Balkans2011/810/EU: Council Decision of 30 November 2011 establishing the position to be taken by the European Union within the General Council of the World Trade Organization as regards requests for granting and/or extending certain WTO waivers2011/827/EU: Council Implementing Decision of 30 November 2011 amending Implementing Decision 2011/77/EU on granting Union financial assistance to Ireland2011/786/EU: Commission Decision of 29 November 2011 on the safety requirements to be met by European standards for bicycles, bicycles for young children, and luggage carriers for bicycles pursuant to Directive 2001/95/EC of the European Parliament and of the Council Text with EEA relevance2011/853/EU: Council Decision of 29 November 2011 on the signing, on behalf of the Union, of the European Convention on the legal protection of services based on, or consisting of, conditional accessCouncil Decision 2011/764/CFSP of 28 November 2011 repealing Decision 2011/210/CFSP on a European Union military operation in support of humanitarian assistance operations in response to the crisis situation in Libya (EUFOR Libya)2011/778/EU: Commission Implementing Decision of 28 November 2011 authorising certain Member States to provide for temporary derogations from certain provisions of Council Directive 2000/29/EC in respect of seed potatoes originating in certain provinces of Canada (notified under document C(2011) 8633)2011/780/EU: Council Decision of 28 November 2011 on the position to be taken by the European Union in the EEA Joint Committee concerning an amendment to Annex XIII (Transport) to the EEA Agreement2011/785/EU: Commission Implementing Decision of 28 November 2011 amending Decision 2008/911/EC establishing a list of herbal substances, preparations and combinations thereof for use in traditional herbal medicinal products (notified under document C(2011) 7382) Text with EEA relevanceCommission Decision of 28 November 2011 on the conclusion, on behalf of the European Union of the Monetary Agreement between the European Union and the Principality of Monaco

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next